Alexandria Real Estate Equities | Omløpsmidler

Current Assets Endring Dato
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Eli Lilly USD 25.19B 2.18B 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Illumina USD 2.58B 26M 2024-03
Quest Diagnostics USD 2.23B 144M 2024-03



Alexandria Real Estate Equities Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.